Factors such as the surging geriatric population, escalating per capita income, soaring number of patients with psoriasis, rising number of research programs, and booming healthcare spending will drive the psoriasis drugs market at a CAGR of 14.0% during the forecast period (2021–2030).

Factors such as the surging geriatric population, escalating per capita income, soaring number of patients with psoriasis, rising number of research programs, and booming healthcare spending will drive the psoriasis drugs market at a CAGR of 14.0% during the forecast period (2021–2030).